Showing : 1–6 of 24
A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation
The AEIOU Trial Matthew R. Reynolds , J. Scott Allison , Andrea Natale , Ian L. Weisberg , Kenneth A. Ellenbogen , Mark Richards , Wen-Hua Hsieh , Julie Sutherland and Christopher P. Cannon
Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.
The goal of this study was to evaluate the cost-effectiveness of TAVR with a self-expanding prosthesis compared with surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and high surgical risk. Reynolds MR, Lei Y, Wang K, Chinnakondepalli K, Vilain KA, Magnuson EA, Galper BZ, Meduri CU, Arnold SV, Baron SJ, Reardon MJ, Adams DH, Popma JJ, Cohen DJ; CoreValve US High Risk Pivotal Trial Investigators.
Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study
Murphy TP 1 , Cutlip DE 2 , Regensteiner JG 3 , Mohler ER 3rd 4 , Cohen DJ 5 , Reynolds MR 6 , Massaro JM 7 , Lewis BA 8 , Cerezo J 9 , Oldenburg NC 10 , Thum CC 6 , Jaff MR 11 , Comerota AJ 12 , Steffes MW 10 , Abrahamsen IH 6 , Goldberg S 13 , Hirsch AT 10 .
Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the placement of aortic transcatheter valve trial
Arnold SV 1 , Lei Y 2 , Reynolds MR 2 , Magnuson EA 2 , Suri RM 2 , Tuzcu EM 2 , Petersen JL 2nd 2 , Douglas PS 2 , Svensson LG 2 , Gada H 2 , Thourani VH 2 , Kodali SK 2 , Mack MJ 2 , Leon MB 2 , Cohen DJ 2 ; PARTNER Investigators.
Improved Functional Status and Quality of Life in Prohibitive Surgical Risk Patients With Degenerative Mitral Regurgitation Following Transcatheter Mitral Valve Repair with the MitraClip® System.
Lim DS , Reynolds MR , Feldman T , Kar S , Herrmann HC , Wang A , Whitlow PL , Gray WA , Grayburn P , Mack MJ , Glower D .